Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
REPH > SEC Filings for REPH > Form 8-K on 17-Jun-2014All Recent SEC Filings

Show all filings for RECRO PHARMA, INC.

Form 8-K for RECRO PHARMA, INC.


17-Jun-2014

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On June 17, 2014, Recro Pharma, Inc. issued a press release announcing the dosing of the first patient in the Phase IIb study of Dex-IN in patients undergoing bunionectomy surgery. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibit is filed herewith:

99.1 Press release, dated June 17, 2014


  Add REPH to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for REPH - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.